Korean Circ J.  2011 Jul;41(7):354-355. 10.4070/kcj.2011.41.7.354.

Prognostic Impact of Early ST-Segment Resolution and Biochemical Markers in Patients With ST-Elevation Myocardial Infarction

• Chung IM

• KMID: 2225097
• DOI: http://doi.org/10.4070/kcj.2011.41.7.354

Abstract

No abstract available.

MeSH Terms

Biomarkers
Humans
Myocardial Infarction

Figure

• 

  Fig. 1 The thirty-day cardiac mortality rates by the ST resolution risk groups with the ECG recorded at 90 minutes after onset of STEMI in 2,719 patients of the InTIME II Study. STR: resolution of ST-segment elevation, max STE: the maximum ST-segment deviation in a single lead.5)

Reference

1. Scirica BM. Acute coronary syndrome: emerging tools for diagnosis and risk assessment. J Am Coll Cardiol. 2010. 55:1403–1415.

2. Maroko PR, Kjekshus JK, Sobel BE, et al. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971. 43:67–82.

3. van't Hof AW, Liem A, de Boer MJ, Zijlstra F. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction: Zwolle Myocardial Infarction Study Group. Lancet. 1997. 350:615–619.

4. de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol. 2001. 38:1283–1294.

5. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation. 2004. 110:e506–e510.

6. Woo JS, Cho JM, Kim SJ, Kim MK, Kim CJ. Combined Assessments of Biochemical Markers and ST-Segment Resolution Provide Additional Prognostic Information for Patients with ST-Segment Elevation Myocardial Infarction. Korean Circ J. 2011. 41:372–378.

7. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007. 115:e356–e375.

8. Anzai T, Yoshikawa T, Shiraki H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation. 1997. 96:778–784.

9. Sabatine MS, Morrow DA, Higgins LJ, et al. Complimentary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation. 2008. 117:1936–1944.